Market Cap (In USD)
2042.00
Revenue (In USD)
-18.5 Thousand
Net Income (In USD)
-15.23 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-6-2.0E-5
- PE
- -
- EPS
- -
- Beta Value
- 451.658
- ISIN
- US53215R1005
- CUSIP
- 53215R100
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. M. Richard Wadley
- Employee Count
- -
- Website
- https://www.lifepointinc.org
- Ipo Date
- 1994-11-01
- Details
- LifePoint, Inc. develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device. It serves workplaces, ambulances, pharmacies, law enforcements, and home health care markets. LifePoint, Inc. was formerly known as US Drug Testing, Inc. and changed its name to LifePoint, Inc. in February 1998. The company was incorporated in 1992 and is based in Ontario, California.
More Stocks
-
029530sindoh Co.,Ltd.
029530
-
BPCPBioPharma Credit PLC
BPCP
-
6099Elan Corporation
6099
-
092730NeoPharm CO., LTD.
092730
-
SAGD
-
003620Ssangyong Motor Company
003620
-
002880Dayou A-Tech Co.,Ltd
002880
-
SOUL